DoubleLine ETF Adviser’s Sabra Healthcare REIT SBRA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$249K	Sell	12,938 -2,586	-17%	-$50.9K	0.09%	158
2025 Q4	$294K	Buy	15,524 +695	+5%	+$12.9K	0.09%	154
2025 Q3	$276K	Buy	14,829 +775	+6%	+$14.5K	0.08%	143
2025 Q2	$259K	Buy	14,054 +270	+2%	+$4.79K	0.08%	146
2025 Q1	$241K	Sell	13,784 -3,018	-18%	-$50.9K	0.08%	159
2024 Q4	$291K	Buy	16,802 +62	+0.4%	+$1.13K	0.08%	146
2024 Q3	$312K	Buy	+16,740	New	+$282K	0.08%	177
2024 Q2	–	Sell	-17,551	Closed	-$259K	–	234
2024 Q1	$259K	Buy	17,551 +1,609	+10%	+$22.3K	0.07%	186
2023 Q4	$227K	Buy	+15,942	New	+$226K	0.07%	191
2023 Q2	–	Sell	-11,646	Closed	-$134K	–	241
2023 Q1	$134K	Buy	11,646 +1,429	+14%	+$17.7K	0.06%	194
2022 Q4	$127K	Buy	+10,217	New	+$130K	0.07%	190